Charles Explorer logo
🇬🇧

Insulin glargine 300 U/ml (Toujeo) - an optimal basal insulin for a geriatric patient treated for type 1 diabetes mellitus

Publication at Second Faculty of Medicine |
2018

Abstract

A case report of 83-year-old woman treated almost 30 years for type 1 diabetes mellitus by intensified insulin regime is reported. Regarding chronic diabetic complications she is suffering from severe distal sensitive neuropathy.

She has other co-morbidities as well which are not primarily connected to diabetes. She can be described as a slim and very active lady with multiple hobbies.

Her diabetes stabilisation was not optimal and the major treatment challenge represented recurrent severe hypoglycaemias. The patient refused insulin pump therapy.

The situation was finally stabilised by using glargine 300 U/mL as a basal insulin instead of glargine 100 U/mL. The type of prandial insulin remained unchanged.